Tumor-intrinsic chromatin programs enforce immune evasion in glioblastoma
Journal of Clinical Investigation · 02.03.2026 · 136 (5)
DOI: 10.1172/jci203222 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.03.2026. Verfasst von Raymond Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery and. Hauptthemen laut MEDLINE: Glioblastoma, Chromatin, Brain Neoplasms, Tumor Escape. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery and.
- Helen Diller Comprehensive Cancer Center, UCSF, San Francisco, California, USA.
- Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
Förderung
- NINDS NIH HHS
Zitieren
APA
Sun, R., Gao, C., & Lu, R. O. (2026). Tumor-intrinsic chromatin programs enforce immune evasion in glioblastoma. Journal of Clinical Investigation, 136(5). https://doi.org/10.1172/jci203222
Vancouver
Sun R, Gao C, Lu RO. Tumor-intrinsic chromatin programs enforce immune evasion in glioblastoma. Journal of Clinical Investigation. 2026;136(5). doi:10.1172/jci203222
BibTeX
@article{Sun2026,
author = {Sun, Raymond and Gao, Chao and Lu, Rongze Olivia},
title = {Tumor-intrinsic chromatin programs enforce immune evasion in glioblastoma},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {5},
doi = {10.1172/jci203222}
}
EUVIMED